BioCryst Pharmaceuticals

BCRX NASDAQ IPO1994

about BCRX

BioCryst Pharmaceuticals specializes in creating life-saving treatments for rare conditions through cutting-edge research and development.

type open high low market
cap
volume
stock $7.67 $7.69 $7.46 $1.9B 3.37M
eps price to
earnings
price to
sales
operating
margin
profit
margin
yield
+$0.06 755.04 10.42 18.56% 8.09% 0%